Clinical Trial: Cardiovascular - smartADHERE

Overview

smartADHERE*

Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation

Objective

To evaluate the effectiveness of an intervention with a mobile adherence platform, compared to physician - or nurse - guided standard of care, to improve medication adherence to rivaroxaban in subjects who have recently initiated treatment with rivaroxaban for stroke prevention in atrial fibrillation based on an assessment of the PDC, (proportion of days covered) of rivaroxaban treatment.

Study Coordinator(s)

Stephanie Porenta, RN: 425.467.3986, Stephanie.Porenta@overlakehospital.org 

Complete the online contact information form. 

Learn More

• ClinicalTrials.gov

Principal Investigator(s)

Thomas Amidon, MD

Clinical Trial Categories

Cardiovascular

*NOTE: THIS TRIAL IS NO LONGER ACCEPTING NEW PATIENTS.